# Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)

> **NCT01573715** · PHASE4 · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 40 (estimated)

## Conditions studied

- Acute Respiratory Distress Syndrome

## Interventions

- **DRUG:** NIMBEX
- **DRUG:** NIMBEX
- **OTHER:** WITHOUT NIMBEX

## Key facts

- **NCT ID:** NCT01573715
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2014-09
- **Final completion:** 2014-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01573715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01573715, "Effects of Neuromuscular Blocking Agents (NMBA) on the Alteration of Transpulmonary Pressures at the Early Phase of Acute Respiratory Distress Syndrome (ARDS)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01573715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*